A novel catheter ablation strategy for non-paroxysmal atrial fibrillation combining cryoballoon, radiofrequency, and Marshall-vein ethanol ablations.
Kazuto HayasakaTakeshi SasakiYasuhiro ShiraiHikaru ShimosatoTomohiro TaharaShota SegamiRyo NagasawaKo AkimotoKento YabeChisashi ToyaKeita WatanabeShu YamashitaMasahito SuzukiKoji SugiyamaYasuteru YamauchiKaoru OkishigeMasahiko GoyaTetsuo SasanoPublished in: Pacing and clinical electrophysiology : PACE (2023)
Approximately 80% of the study patients were AF-free during 1-year follow-up period after a single procedure based on the novel extensive ablation strategy combining CBA, RFA, and EA-VOM. This strategy for non-PAF may be preferred in terms of maintenance of sinus rhythm, safety even in high-risk patients, and relatively short procedure time.
Keyphrases
- atrial fibrillation
- catheter ablation
- end stage renal disease
- left atrial
- left atrial appendage
- ejection fraction
- newly diagnosed
- oral anticoagulants
- chronic kidney disease
- heart failure
- coronary artery disease
- minimally invasive
- direct oral anticoagulants
- percutaneous coronary intervention
- venous thromboembolism
- radiofrequency ablation
- acute coronary syndrome
- left ventricular